John Overdeck’s WisdomTree US SmallCap Earnings Fund EES Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$712K Sell
10,500
-8,000
-43% -$508K ﹤0.01% 3883
2026
Q1
$1.07M Buy
18,500
+8,400
+83% +$496K ﹤0.01% 3219
2025
Q4
$575K Buy
10,100
+5,900
+140% +$330K ﹤0.01% 3230
2025
Q3
$235K Sell
4,200
-41,500
-91% -$2.25M ﹤0.01% 3320
2025
Q2
$2.33M Sell
45,700
-35,300
-44% -$1.7M ﹤0.01% 1726
2025
Q1
$3.96M Buy
81,000
+65,100
+409% +$3.43M 0.01% 1252
2024
Q4
$858K Buy
15,900
+800
+5% +$43.9K ﹤0.01% 2269
2024
Q3
$797K Buy
15,100
+300
+2% +$15.2K ﹤0.01% 2241
2024
Q2
$698K Sell
14,800
-100
-0.7% -$4.79K ﹤0.01% 2197
2024
Q1
$747K Buy
14,900
+400
+3% +$19.2K ﹤0.01% 2134
2023
Q4
$722K Buy
14,500
+8,200
+130% +$363K ﹤0.01% 2262
2023
Q3
$273K Buy
+6,300
New +$287K ﹤0.01% 2523

Other funds holding EES

John Overdeck's EES Position: Q2 2026 in Review

John Overdeck reduced its WisdomTree US SmallCap Earnings Fund (EES) stake by 43% in Q2 2026, selling an estimated $508K and leaving 10,500 shares worth $712K. The position accounts for ﹤0.01% of the portfolio, ranked #3883.

John Overdeck first reported a position in EES in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.96M in Q1 2025. 170 funds tracked by Wall St. Rank hold EES as of Q2 2026.

  • John Overdeck held 10,500 shares of WisdomTree US SmallCap Earnings Fund worth $712K as of Q2 2026.
  • John Overdeck sold 8,000 WisdomTree US SmallCap Earnings Fund shares in Q2 2026, an estimated $508K.
  • WisdomTree US SmallCap Earnings Fund made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3883 holding.
  • John Overdeck first reported a position in WisdomTree US SmallCap Earnings Fund in Q3 2023 and has held it in 12 quarters since.
  • John Overdeck's WisdomTree US SmallCap Earnings Fund position peaked at $3.96M in Q1 2025.
  • 170 funds tracked by Wall St. Rank held WisdomTree US SmallCap Earnings Fund as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.